======= RNASEH2C ======= == Gene Information == * **Official Symbol**: RNASEH2C * **Official Name**: ribonuclease H2 subunit C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84153|84153]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TDP1|Q8TDP1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RNASEH2C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNASEH2C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610330|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a ribonuclease H subunit that can cleave ribonucleotides from RNA:DNA duplexes. Mutations in this gene cause Aicardi-Goutieres syndrome-3, a disease that causes severe neurologic dysfunction. A pseudogene for this gene has been identified on chromosome Y, near the sex determining region Y (SRY) gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}. |RNase H2 suC| |ribonuclease H2 complex| |RNA catabolic process| |nucleobase-containing compound catabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |organic cyclic compound catabolic process| |cellular macromolecule catabolic process| |macromolecule catabolic process| |RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.14| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|1.72| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|1.82| ^Gene^Correlation^ |[[:human genes:r:rnaseh2a|RNASEH2A]]|0.512| |[[:human genes:r:rnaseh2b|RNASEH2B]]|0.402| Global Fraction of Cell Lines Where Essential: 34/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|2/26| |breast|2/33| |central nervous system|3/56| |cervix|0/4| |colorectal|0/17| |esophagus|1/13| |fibroblast|0/1| |gastric|0/16| |kidney|3/21| |liver|0/20| |lung|3/75| |lymphocyte|1/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|4/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4057 * **Expression level (log2 read counts)**: 5.74 {{:chemogenomics:nalm6 dist.png?nolink |}}